- Report
- August 2023
- 70 Pages
South Korea
From €4567EUR$4,750USD£3,918GBP
- Report
- October 2022
- 70 Pages
Africa
From €4567EUR$4,750USD£3,918GBP
- Report
- August 2020
- 150 Pages
Global
From €4087EUR$4,250USD£3,506GBP
- Report
- October 2019
- 125 Pages
Canada
From €4567EUR$4,750USD£3,918GBP
- Report
- April 2023
- 110 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- July 2021
- 50 Pages
China
From €2500EUR$2,600USD£2,145GBP
- Report
- June 2021
- 50 Pages
China
From €2500EUR$2,600USD£2,145GBP
- Report
- May 2021
- 50 Pages
China
From €2500EUR$2,600USD£2,145GBP
- Report
- October 2022
- 138 Pages
Global
From €4279EUR$4,450USD£3,671GBP
- Report
- May 2020
- 121 Pages
Global
From €4183EUR$4,350USD£3,588GBP
- Drug Pipelines
- February 2018
- 207 Pages
Global
From €21154EUR$22,000USD£18,147GBP
- Report
- September 2023
- 94 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- September 2023
- 98 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- September 2023
- 86 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- January 2021
- 145 Pages
China, Global
From €3000EUR$3,342USD£2,664GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- February 2024
- 108 Pages
Global
From €3500EUR$3,899USD£3,108GBP
- Report
- October 2022
- 286 Pages
Global
From €2404EUR$2,500USD£2,062GBP
Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more